Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 17 of 663 for:    SMS

SMS Mobile Technology to Improve Early Childhood Vaccine Coverage in Guatemala (SMSVaxGuate)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02567006
Recruitment Status : Completed
First Posted : October 2, 2015
Last Update Posted : September 26, 2019
Sponsor:
Collaborators:
Universidad del Valle, Guatemala
Fundacion para la Salud Integral de los Guatemaltecos CU
Ministry of Health, Guatemala
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by (Responsible Party):
University of Colorado, Denver

Brief Summary:
This project plans to learn more about whether sending text messages to parents on their mobile phones to remind them when their child is due for his or her next vaccination will improve children getting vaccinated on time.

Condition or disease Intervention/treatment Phase
Adherence to Vaccination Schedules Timeliness of Vaccination Acceptability of SMS Reminder Program Behavioral: SMS message Other: Usual care Not Applicable

Detailed Description:
This project plans to learn more about whether sending text messages to parents on their mobile phones to remind them when their child is due for his or her next vaccination will improve children getting vaccinated on time. The vaccines that will be given are the same routine vaccinations registered in Guatemala and used by the Ministry of Health regardless of enrollment in the study.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 720 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: SMS Mobile Technology to Improve Early Childhood Vaccine Coverage in Guatemala
Actual Study Start Date : March 1, 2016
Actual Primary Completion Date : July 7, 2017
Actual Study Completion Date : July 10, 2017

Arm Intervention/treatment
Active Comparator: Short Message Service (SMS) group
Receiving SMS message reminders 1 week before scheduled vaccination
Behavioral: SMS message
SMS messages will be delivered at 6, 4, and 2 days before the next scheduled date of the primary vaccines for the intervention group
Other Name: text messages

Placebo Comparator: Usual care
Not receiving SMS messages
Other: Usual care
Health clinic nurse provides regular appointment in the vaccination card with no active reminders




Primary Outcome Measures :
  1. Completion of vaccine primary series [ Time Frame: 12 months of age ]
    Completion of 2nd and 3rd dose of vaccines by 1 year of age


Secondary Outcome Measures :
  1. Factors associated with immunization delays [ Time Frame: 12 months ]
    Demographic, education and behavioral factors associated with days late for vaccination

  2. Acceptability of SMS vaccine reminders [ Time Frame: 12 months ]
    Qualitative data from focus groups to evaluate acceptability of SMS program

  3. Timeliness of immunization [ Time Frame: 12 months ]
    Days delayed from date for 2nd and 3rd dose of vaccination



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   6 Weeks to 6 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • First dose of primary vaccination series
  • Parents owning a mobile phone and able to decipher SMS messages
  • Consent form signed

Exclusion Criteria:

  • Moving away from the study site in the next 12 months
  • Ineligible for primary vaccination series by the MOH

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02567006


Locations
Layout table for location information
Guatemala
Fundacion para la Salud Integral de los Guatemaltecos CU
Coatepeque, Quetzaltenango, Guatemala
University del Valle, Guatemala
Guatemala, Guatemala, 01015
Sponsors and Collaborators
University of Colorado, Denver
Universidad del Valle, Guatemala
Fundacion para la Salud Integral de los Guatemaltecos CU
Ministry of Health, Guatemala
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Investigators
Layout table for investigator information
Study Chair: Edwin J Asturias, MD University of Colorado, Denver
Principal Investigator: Gretchen Domek, MD University of Colorado, Denver
Study Director: Ingrid L Contreras, MD University del Valle, Guatemala

Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: University of Colorado, Denver
ClinicalTrials.gov Identifier: NCT02567006     History of Changes
Other Study ID Numbers: 14-2170
1R21HD084115-01 ( U.S. NIH Grant/Contract )
First Posted: October 2, 2015    Key Record Dates
Last Update Posted: September 26, 2019
Last Verified: September 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University of Colorado, Denver:
vaccines
reminders
immunization timeliness
vaccine coverage
Additional relevant MeSH terms:
Layout table for MeSH terms
Vaccines
Immunologic Factors
Physiological Effects of Drugs